PPARA and temporal lobe epilepsy: Our study provides the first comprehensive evidence that the PPARα agonist fenofibrate exerts a complex, region-specific modulation of neuroinflammation and synaptic plasticity during the latent phase of the lithium-pilocarpine model of temporal lobe epilepsy.